- Home
- ACLS vs MANE Comparison
ACLS vs MANE Comparison
Compare ACLS & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACLS | MANE |
|---|---|---|
| Founded | 1995 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.3B |
| IPO Year | 2000 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ACLS | MANE |
|---|---|---|
| Price | $123.07 | $117.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $101.50 | $83.33 |
| AVG Volume (30 Days) | 290.3K | ★ 604.3K |
| Earning Date | 05-07-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $839,048,000.00 | N/A |
| Revenue This Year | $1.93 | N/A |
| Revenue Next Year | $7.91 | N/A |
| P/E Ratio | $110.61 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $73.60 | $36.26 |
| 52 Week High | $193.78 | $131.24 |
Technical Indicators
Market Signals| Indicator | ACLS | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 55.55 | 64.38 |
| Support Level | $105.26 | $92.62 |
| Resistance Level | $147.88 | $130.52 |
| Average True Range (ATR) | 4.56 | 5.86 |
| MACD | 2.19 | 2.09 |
| Stochastic Oscillator | 98.79 | 82.65 |
Price Performance
Historical ComparisonAbout ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.